Similar articles

• Immunogenetic factors in skin cancer.

  Streilein JW. Streilein JW. N Engl J Med. 1991 Sep 19;325(12):884-7. doi: 10.1056/NEJM199109193251210. N Engl J Med. 1991. PMID: 1875975 No abstract available.
• [HLA antigens in cutaneous malignant lymphoma].

  Yotsumoto H, Shimokawa Y, Nomoto S, Tashiro M, Sakai K. Yotsumoto H, et al. Nihon Hifuka Gakkai Zasshi. 1983 Jul;93(8):875-6. Nihon Hifuka Gakkai Zasshi. 1983. PMID: 6655959 Japanese. No abstract available.
• [HLA system and haemangiomas (author's transl)].

  Abrahámová J, Májský A, Bek V. Abrahámová J, et al. Cas Lek Cesk. 1980 Jan 11;119(2):54-5. Cas Lek Cesk. 1980. PMID: 7371057 Czech. No abstract available.
• The role of HLA molecules in the development of skin cancer.

  Bouwes Bavinck JN, Claas FH. Bouwes Bavinck JN, et al. Hum Immunol. 1994 Nov;41(3):173-9. doi: 10.1016/0198-8859(94)90033-7. Hum Immunol. 1994. PMID: 7868372 Review. No abstract available.
• HLA-G in the skin--friend or foe?

  Urosevic M. Urosevic M. Semin Cancer Biol. 2007 Dec;17(6):480-4. doi: 10.1016/j.semcancer.2007.09.001. Epub 2007 Sep 19. Semin Cancer Biol. 2007. PMID: 17981049 Review.